FBXL16 promotes cell growth and drug resistance in lung adenocarcinomas with KRAS mutation by stabilizing IRS1 and upregulating IRS1/AKT signaling.
Morel M, Long W
Mol Oncol. 2024 Mar;18(3):762-777. doi: 10.1002/1878-0261.13554. Epub 2024 Jan 17.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.